All stock lists
Alkami Technology, Inc. (NASDAQ:ALKT)
US · Delayed Price · Currency is USD
Technology · Software - Application
15.71-0.33 (-2.03%)
Insider Score
––Not scored
ALKT Insider Score
Insiders here have filed 11 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ALKT analyst forecast
ALKT analyst consensus
Hold4 ratings
Buy 2 Hold 1 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ALKT 12-month price target
$25.50+63.1% upsideaverage of 2 firms
$26.00High
$25.00Low
Best analysts covering ALKT
- Needham71%success rate · 14 calls
- JP Morgan60%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ALKT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-12 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2026-09-24 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-09-24 |
| Needham | Buy | $25.00 | +22.7% | Reiterated | 2026-08-24 | |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-06-22 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-30 |
| Needham | Buy | $22.00 | +34.4% | Reiterated | 2026-02-26 | |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-02-26 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-02-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-02-18 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-01-29 |
| Goldman Sachs | Neutral | $26.00 | +18.2% | Reiterated | 2025-11-03 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-10-31 |
| Needham | Buy | $32.00 | +60.0% | Reiterated | 2025-10-31 | |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-10-31 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-31 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-01 |
| — | Lake Street | Buy | — | — | Reiterated | 2025-05-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-05-01 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-04-14 |
| — | Stephens & Co. | Overweight | — | — | Upgraded | 2025-03-13 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-03-03 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-03-03 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-12-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-11-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-10-31 |
| Craig-Hallum | Buy | $45.00 | +10.7% | Reiterated | 2024-10-31 | |
| Needham | Buy | $54.00 | +41.4% | Reiterated | 2024-10-31 | |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-10-31 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-10-29 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-08-01 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-08-01 |
| — | Lake Street | Buy | — | — | Reiterated | 2024-08-01 |
| JMP Securities | Market Outperform | $38.00 | +16.1% | Reiterated | 2024-08-01 | |
| — | Needham | Buy | — | — | Reiterated | 2024-08-01 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-08-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-07-22 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-07-11 |
| — | Needham | Buy | — | — | Reiterated | 2024-06-25 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-02 |
| Craig-Hallum | Buy | $31.00 | +27.0% | Reiterated | 2024-05-02 | |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-04-15 |
| — | Needham | Buy | — | — | Reiterated | 2024-02-29 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-02-29 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-02-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-02-29 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-01-24 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2024-01-23 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-01-08 |
| — | Needham | Buy | — | — | Reiterated | 2024-01-05 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-01-04 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2023-12-07 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2023-11-03 |
| — | Needham | Buy | — | — | Reiterated | 2023-11-02 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-11-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-08-10 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-08-04 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-08-03 |
| — | Needham | Buy | — | — | Reiterated | 2023-08-03 |
ALKT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | 0.15 | 0.10 | $120.1M | $120.8M |
| 2026-04-29 | 0.21 | 0.04 | $125.2M | $126.1M |
| 2026-07-29 | 0.15 | 0.12 | $128.7M | $129.8M |
| 2026-10-28 | 0.20 | 0.00 | $133.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.